Sage Therapeutics Inc.
11/26/2024 | Press release | Distributed by Public on 11/26/2024 15:49
Management Change/Compensation Form 8 K
| Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On November 22, 2024, Jeffrey M. Jonas, MD, a member of the Board of Directors (the "Board") of Sage Therapeutics, Inc. (the "Company"), notified the Company of his retirement from the Board, effective as of December 1, 2024. Dr. Jonas's retirement is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.